Pacira BioSciences announces director Yvonne Greenstreet to retire from board

Pacira BioSciences, Inc.

Yvonne Greenstreet, independent director for 9 years, retiring effective March 31, 2023.
Greenstreet is CEO of Alnylam Pharmaceuticals; retirement not due to any disagreement.
Pacira will initiate search for an independent board member to replace her.

item 5.02 item 7.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Yvonne Greenstreet

Director

PCRX · Pacira BioSciences, Inc.

Effective: 2023-03-31
Filed: March 22, 2023, 7:59 PM ET

On March 18, 2023, Yvonne Greenstreet notified the Board of Directors (the “Board”) of Pacira BioSciences, Inc. (the “Company”) of her intent to of her intent to retire from the Board, effective March 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Yvonne Greenstreet departed as Director at Pacira BioSciences, Inc..

Action: retire
Role: Director

Exact text from the filing

On March 18, 2023, Yvonne Greenstreet notified the Board of Directors (the “Board”) of Pacira BioSciences, Inc. (the “Company”) of her intent to of her intent to retire from the Board, effective March 31, 2023.

View on SEC.gov

Pacira BioSciences, Inc. filing history →

Source: SEC EDGAR

accession 0001396814-23-000013

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.